Moderna
MRNA
#270
Rank
HK$704.89 B
Marketcap
HK$1,766
Share price
14.21%
Change (1 day)
724.13%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: HK$704.89 Billion

As of October 2026 Moderna has a market cap of HK$704.89 Billion. This makes Moderna the world's 270th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$704.89 B643.15%
2025HK$94.85 B-20.88%
2024HK$119.88 B-59.52%
2023HK$296.14 B-45.07%
2022HK$539.16 B-32.85%
2021HK$802.96 B150.55%
2020HK$320.47 B525.11%
2019HK$51.26 B30.39%
2018HK$39.31 B

End of Day market cap according to different sources

On Oct 9th, 2026 the market cap of Moderna was reported to be:

HK$704.89 Billion
by Nasdaq info icon info icon
HK$704.89 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$4.944 T 601.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$2.144 T 204.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
HK$2.818 T 299.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
HK$4.43 B-99.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
HK$23.36 B-96.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
HK$6.53 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$244.32 B-65.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
HK$69.35 B-90.16%๐Ÿ‡บ๐Ÿ‡ธ USA